Blood-Brain Barrier And Cerebral Perfusion Practice Test

The main concept is that MR perfusion and CT perfusion rely on different types of contrast agents because the imaging physics and how the contrast behaves in tissue differ. For MR perfusion, gadolinium-based contrast agents are used because they affect magnetic relaxation properties, allowing dynamic susceptibility or T1/T2 changes to be tracked as contrast passes through the brain’s microvasculature. For CT perfusion, iodinated contrast agents are used because they change X-ray attenuation, which CT measures as changes in Hounsfield units over time. These agents also differ in how they behave in tissue and with the blood–brain barrier. Gadolinium-based agents can leak from vessels into the interstitial space when the BBB is compromised, which can alter MR signal in ways that complicate perfusion measurements unless leakage is accounted for (for example, with preload strategies or leakage-correction algorithms). Iodinated contrast mainly stays within the intravascular and extracellular space, and while BBB disruption can affect its distribution, the imaging and quantification methods in CT perfusion handle these changes differently. In short, the two modalities use different contrast agents because the underlying physics dictate distinct ways to measure perfusion, and this leads to differences in how BBB integrity and leakage influence the results.